Anemia management and mortality risk in incident hemodialysis patients
- PMID: 20606145
- DOI: 10.1001/jama.2010.890
Anemia management and mortality risk in incident hemodialysis patients
Comment on
-
Comparative mortality risk of anemia management practices in incident hemodialysis patients.JAMA. 2010 Mar 3;303(9):857-64. doi: 10.1001/jama.2010.206. JAMA. 2010. PMID: 20197532
Similar articles
-
Iron in the treatment of anemia in dialysis patients: an important support to erythropoietin.Int J Artif Organs. 1998 Nov;21(11):681-6. Int J Artif Organs. 1998. PMID: 9894741 No abstract available.
-
[Treatment with high-dose intravenous iron increases mortality and hospitalization in hemodialysis. The basic idea is more important than the style].Nefrologia. 2005;25(3):340. Nefrologia. 2005. PMID: 16053019 Spanish. No abstract available.
-
[Treatment with high dose of intravenous iron increases mortality and hospitalization in hemodialysis].Nefrologia. 2004;24(1):87-8. Nefrologia. 2004. PMID: 15083966 Spanish. No abstract available.
-
Intravenous iron: the iatrogenic kick to lose control over oxygen?Kidney Blood Press Res. 2002;25(5):284-8. doi: 10.1159/000066793. Kidney Blood Press Res. 2002. PMID: 12435873 Review.
-
Management of iron deficiency in renal anemia: guidelines for the optimal therapeutic approach in erythropoietin-treated patients.Clin Nephrol. 1997 Jul;48(1):1-8. Clin Nephrol. 1997. PMID: 9247771 Review.
Cited by
-
Epoetin alfa resistance in hemodialysis patients with chronic kidney disease: a longitudinal study.Braz J Med Biol Res. 2018;51(7):e7288. doi: 10.1590/1414-431x20187288. Epub 2018 May 7. Braz J Med Biol Res. 2018. PMID: 29742267 Free PMC article.
-
Glycochenodeoxycholate Affects Iron Homeostasis via Up-Regulating Hepcidin Expression.Nutrients. 2022 Aug 2;14(15):3176. doi: 10.3390/nu14153176. Nutrients. 2022. PMID: 35956351 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical